Gastric cancer (GC) is one of the most common malignancies and is the leading global cause of death by cancer. Over recent decades, targeted therapies and immunotherapy have become significant new approaches for the treatment of GC.

Ferroptosis is a newly verified form of modulated cell death that is characterized by lipid peroxidation. Further exploration of the function of ferroptosis in the progression of GC has provided novel opportunities for diagnosis and treatment.

The overexpression of MGST1 induced the activation of the Akt/GSK-3β pathway. An Akt inhibitor antagonized the inhibitory effects of MGST1 on autophagy and ferroptosis.

MGST1 and ATG16L1 overexpression, and MGST1 depletion assay were conducted by Medicilon.

Reference:

Z Peng,N Peng. Microsomal glutathione S-transferase 1 targets the autophagy signaling pathway to suppress ferroptosis in gastric carcinoma cells. Hum Exp Toxicol. 2023 Jan-Dec:42:9603271231172915. doi: 10.1177/09603271231172915.

MGST1 過表達胃癌體外實驗

SIRT6變構激活劑在結直腸癌中發(fā)揮治療作用，本研究中PK實驗通過尊龍凱時進行返回通過聯(lián)合治療提高免疫療法療效，本研究中臨床前體內藥效研究通過尊龍凱時進行

相關新聞

我國學者發(fā)現(xiàn)EB病毒感染受體為鼻咽癌和胃癌防控提供新靶點

2018-01-12

近日，中山大學腫瘤防治中心曾木圣教授課題組和哈佛大學醫(yī)學院趙波教授合作，在EB病毒感染機制研究方面取得重要進展。

胃癌腹膜轉移臨床診療的新進展

2015-06-30

胃癌是我國最常見且高病死率的惡性腫瘤之一. 造成其病死率高的原因主要是胃癌轉移, 其中腹膜轉移是胃癌最常見轉移方式, 占50%以上. 胃癌一旦出現(xiàn)腹膜轉移則臨床病理已屬Ⅳ期, 提示預后極差.

選擇性小分子c-Myc降解劑可有效消退c-Myc過表達的腫瘤，表面等離子共振 (SPR) 實驗通過尊龍凱時進行

2023-07-05

Cancer is one of the leading causes of death worldwide. MYC oncogene is involved in the majority of human cancers and is often associated with poor outcomes. WBC100, a novel oral active molecule glue that selectively degrades c-Myc protein over other proteins and potently kills c-Myc overexpressing cancer cells is reported. Researchers performed direct binding assay of WBC100 with c-Myc on biosensor chip by surface plasmon resonance (SPR). SPR experiments were performed using a Biacore T200 instrument by Medicilon.